聚半乳糖醛酸具有益生元活性,并可降低高脂肪饮食喂养的大鼠的肥胖和非酒精性脂肪性肝病。

Polylactose Exhibits Prebiotic Activity and Reduces Adiposity and Nonalcoholic Fatty Liver Disease in Rats Fed a High-Fat Diet.

机构信息

Department of Food Science and Nutrition, University of Minnesota, St. Paul, MN, USA.

出版信息

J Nutr. 2021 Feb 1;151(2):352-360. doi: 10.1093/jn/nxaa376.

Abstract

BACKGROUND

Prebiotic dietary fibers change the intestinal microbiome favorably and provide a health benefit to the host.

OBJECTIVES

Polylactose is a novel fiber, synthesized by extrusion of lactose. We evaluated its prebiotic activity by determining its fermentability, effect on the microbiota, and effects on adiposity and liver lipids in a diet-induced obesity animal model.

METHODS

Male Wistar rats (4-5 wk old) were fed normal-fat (NF, 25% fat energy) or high-fat (HF, 51% fat energy) diets containing different fibers (6% fiber of interest and 3% cellulose, by weight), including cellulose (NFC and HFC, negative and positive controls, respectively), polylactose (HFPL), lactose matched to residual lactose in the HFPL diet, and 2 established prebiotic fibers: polydextrose (HFPD) and fructooligosaccharide (HFFOS). After 10 wk of feeding, organs were harvested and cecal contents collected.

RESULTS

HFPL animals had greater cecum weight (3 times greater than HFC) and lower cecal pH (∼1 pH unit lower than HFC) than all other groups, suggesting that polylactose is more fermentable than other prebiotic fibers (HFPD, HFFOS; P < 0.05). HFPL animals also had increased taxonomic abundance of the probiotic species Bifidobacterium in the cecum relative to all other groups (P < 0.05). Epididymal fat pad weight was significantly decreased in the HFPL group (29% decrease compared with HFC) compared with all other HF groups (P < 0.05) and did not differ from the NFC group. Liver lipids and cholesterol were reduced in HFPL animals when compared with HFC animals (P < 0.05).

CONCLUSIONS

Polylactose is a fermentable fiber that elicits a beneficial change in the gut microbiota as well as reducing adiposity in rats fed HF diets. These effects of polylactose were greater than those of 2 established prebiotics, fructooligosaccharide and polydextrose, suggesting that polylactose is a potent prebiotic.

摘要

背景

益生元膳食纤维可使肠道微生物组朝着有利的方向变化,并为宿主带来健康益处。

目的

聚乳糖是一种新型纤维,通过乳糖挤压合成。我们通过测定其发酵能力、对微生物群的影响以及在高脂肪饮食诱导的肥胖动物模型中对肥胖和肝脏脂质的影响来评估其益生元活性。

方法

雄性 Wistar 大鼠(4-5 周龄)喂食正常脂肪(NF,25%脂肪能量)或高脂肪(HF,51%脂肪能量)饮食,含有不同纤维(6%感兴趣的纤维和 3%纤维素,按重量计),包括纤维素(NFC 和 HFC,分别为阴性和阳性对照)、聚乳糖(HFPL)、与 HFPL 饮食中残留乳糖相匹配的乳糖和 2 种已建立的益生元纤维:聚右旋糖(HFPD)和低聚果糖(HFFOS)。喂养 10 周后,采集器官并收集盲肠内容物。

结果

与所有其他组相比,HFPL 动物的盲肠重量更大(比 HFC 大 3 倍),盲肠 pH 值更低(比 HFC 低约 1 个单位),这表明聚乳糖比其他益生元纤维(HFPD、HFFOS;P < 0.05)更易发酵。与所有其他组相比,HFPL 动物盲肠中益生菌双歧杆菌的分类丰度也增加(P < 0.05)。与所有其他 HF 组相比,HFPL 组的附睾脂肪垫重量显著降低(与 HFC 相比降低 29%)(P < 0.05),与 NFC 组无差异。与 HFC 动物相比,HFPL 动物的肝脏脂质和胆固醇减少(P < 0.05)。

结论

聚乳糖是一种可发酵纤维,可引起肠道微生物群有益变化,并减少 HF 饮食喂养大鼠的肥胖。聚乳糖的这些作用大于两种已建立的益生元,低聚果糖和聚右旋糖,这表明聚乳糖是一种有效的益生元。

相似文献

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索